Phospholipases have been proposed to contribute to the virulence of Candida albicans. Recently, a candidal strain deleted for PLB1, the gene encoding the predominant phospholipase B (Plb1) secreted by C. albicans, was constructed and its virulence in an intravenous murine model of disseminated candidiasis was evaluated. In the present study, the PLB1 gene was reintroduced back into the plb1 null mutant to generate the revertant strain, which showed similar growth and morphology to its isogenic parent strain. Virulence of the revertant strain was found to be comparable to that of the parent strain in an intravenous murine model of disseminated candidiasis. To compare the abilities of the plb1 null mutant, the revertant and the isogenic parent strains to cross the gastrointestinal (GI) tract and cause systemic infection, an oral–intragastric infant mouse model of candidiasis was used. Histological examinations and analysis of c.f.u. of the pathogen in liver homogenates revealed that the parental and revertant strains were able to invade and traverse the GI mucosa to a significantly greater extent than the plb1 null mutant. Immunofluorescence and immunoelectron microscopic studies of infected host tissue using anti-Plb1 antibody showed that Plb1 is secreted during invasion of the gastric mucosa by the parental and revertant strains. In contrast, little or no labelling was observed in the null mutant strain. The results indicate that the Plb1 secreted by C. albicans enhances the ability of this organism to cross the GI tract and disseminate haematogenously. These studies provide unequivocal evidence supporting a role for Plb1 during the course of infection by C. albicans.
Barrett-BeeK., HayesY., WilsonR. G.,
RyleyJ. F.1985; A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol 131:1217–1221
BoekeJ. D., LaCrouteF.,
FinkG. R.1984; A positive selection for mutants lacking orotidine-5′-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol Gen Genet 197:345–346[CrossRef]
ColeG. T., LynnK. T., SeshanK. R.,
PopeL. M.1989; Gastrointestinal and systemic candidosis in immunocompromised mice. J Med Vet Mycol 27:363–380[CrossRef]
ColeG. T., SeshanK. R., PhaneufM.,
LynnK. T.1991a; Chlamydospore-like cells of Candida albicans in the gastrointestinal tract of infected, immunocompromised mice. Can J Microbiol 37:637–646[CrossRef]
ColeG. T., HalawaA. A.,
AnaissieE. J.1996; The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 22 :(suppl. 2)S73–S88
De BackerM. D., de HoogtR. A., FroyenG., OddsF. C., SimonsF., ContrerasR.,
LuytenW. H.2000; Single allele knock-out of Candida albicans CGT1 leads to unexpected resistance to hygromycin B and elevated temperature. Microbiology 146:353–365
EdmondM. B., WallaceS. E., McClishD. K., PfallerM. A., JonesR. N.,
WenzelR. P.1999; Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239–244[CrossRef]
GaleC. A., BendelC. M., McClellanM., HauserM., BeckerJ. M., BermanJ.,
HostetterM. K.1998; Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science 279:1355–1358[CrossRef]
GillumA. M., TsayE. Y.,
KirschD. R.1984; Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198:179–182[CrossRef]
GuentzelM. N.,
HerreraC.1982; Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy. Infect Immun 35:222–228
KlepserM. E., LewisR. E.,
PfallerM. A.1998; Therapy of Candida infections: susceptibility testing, resistance, and therapeutic options. Ann Pharmacother 32:1353–1361[CrossRef]
KruseD.,
ColeG. T.1992; A seroreactive 120-kilodalton β-1,3-glucanase of Coccidioides immitis which may participate in spherule morphogenesis. Infect Immun 60:4350–4363
LeidichS. D., IbrahimA. S., FuY.8 other authors1998; Cloning and disruption of ca PLB1 , a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem 273:26078–26086
MukherjeeP. K.,
GhannoumM. A.2001; Secretory proteins in fungal virulence. In Fungal Pathogenesis: Principles and Clinical Applications pp 51–79 Edited by
CalderoneR. A.,
CihlarR. L.
New York: Marcel Dekker;
PaganoL., AntinoriA., AmmassariA.11 other authors1999; Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes. Eur J Haematol 63:77–85
PughD.,
CawsonR. A.1977; The cytochemical localization of phospholipase in Candida albicans infecting the chick chorio-allantoic membrane. Sabouraudia 15:29–35[CrossRef]
RavdinJ. I., MurphyC. F., GuerrantR. L.,
Long-KrugS. A.1985; Effect of antagonists of calcium and phospholipase A on the cytopathogenicity of Entamoeba histolytica. J Infect Dis 152:542–549[CrossRef]
SafferL. D.,
SchwartzmanJ. D.1991; A soluble phospholipase of Toxoplasma gondii associated with host cell penetration. J Protozool 38:454–460[CrossRef]
SeshanK. R.,
ColeG. T.1994; Structural studies of Coccidioides immitis. In Molecular Biology of Pathogenic Fungi pp 265–273 Edited by
MarescaB.,
KobayashiG. S.
New York: Telos Press;
SilvermanD. J., SantucciL. A., MeyersN.,
SekeyovaZ.1992; Penetration of hosts by Rickettsia rickettsii appears to be mediated by a phospholipase of rickettsial origin. Infect Immun 60:2733–2740
SugiyamaY., NakashimaS., MirbodF., KanohH., KitajimaY., GhannoumM. A.,
NozawaY.1999; Molecular cloning of a second phospholipase B gene, ca PLB2 from Candida albicans . Med Mycol 37:61–67
ViolaA. M., LodiT.,
FerreroI.1999; A Klaac null mutant of Kluyveromyces lactis is complemented by a single copy of the Saccharomyces cerevisiae AAC1 gene. Curr Genet 36:29–36[CrossRef]
ViscoliC., GirmeniaC., MarinusA.9 other authors1999; Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 28:1071–1079[CrossRef]
WeyS. B., MoriM., PfallerM. A., WoolsonR. F.,
WenzelR. P.1988; Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 148:2642–2645[CrossRef]
ZhouD., ChenL. M., HernandezL., ShearsS. B.,
GalanJ. E.2001; A Salmonella inositol polyphosphatase acts in conjunction with other bacterial effectors to promote host cell actin cytoskeleton rearrangements and bacterial internalization. Mol Microbiol 39:248–259[CrossRef]